Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Philadelphia › NPI 1114095791
Hospital

Jefferson Health - Northeast

Jefferson Health - Northeast was paid $14.48M by Medicaid between Oct 2019 and Dec 2024, across 178 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.

33Billing provider infoJEFFERSON HEALTH - NORTHEAST
PHILADELPHIA, PA 19124
33aNPI1114095791assigned 12/01/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$14.48M
24GClaims214,810
24DCodes billed178
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Pennsylvania

Rank by total paid#20 of 154
Median peer was paid$2.82M
This provider vs. median5.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2019370$23K
202034,106$1.99M
202181,036$4.77M
202228,250$2.55M
202329,502$2.83M
2024incomplete41,546$2.32M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 33% 24,934 23,596 $4.73M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 28% 22,163 21,181 $4.12M
G0378 Hospital observation service, per hour 20% 3,461 1,900 $2.89M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.9% 8,892 8,473 $1.44M
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.2% 1,407 1,310 $170K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.2% 1,354 1,316 $168K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,625 1,601 $142K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,553 818 $135K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 1,186 1,157 $72K
36000 <1% 1,455 1,374 $62K
80048 Basic metabolic panel (calcium, ionized) <1% 16,063 13,738 $47K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 362 357 $44K
166 more codes
77063 Screening digital breast tomosynthesis, bilateral <1% 1,266 $29K
70450 Computed tomography, head or brain; without contrast material <1% 1,513 $26K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,317 $22K
71046 Radiologic examination, chest; 2 views <1% 2,125 $19K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 6,383 $19K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 5,156 $18K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 318 $17K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 16,256 $17K
76830 Ultrasound, transvaginal <1% 379 $16K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,239 $14K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 126 $14K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 410 $13K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 1,947 $13K
97161 <1% 137 $11K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 168 $9K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 922 $9K
72125 Computed tomography, cervical spine; without contrast material <1% 484 $9K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 74 $8K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 484 $8K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,950 $6K
0001A <1% 130 $6K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 173 $6K
71045 Radiologic examination, chest; single view <1% 2,556 $6K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 52 $6K
84484 <1% 3,213 $6K
0002A <1% 103 $6K
71250 <1% 103 $5K
70486 <1% 205 $5K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 162 $5K
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 58 $5K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 16 $5K
73630 <1% 566 $5K
96375 Therapeutic injection; each additional sequential IV push <1% 2,075 $4K
72100 <1% 185 $4K
80076 <1% 2,763 $4K
93971 <1% 136 $4K
T1015 A visit at a community health center or clinic (one all-in rate) <1% 59 $4K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 178 $3K
73030 <1% 332 $3K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 166 $3K
76801 <1% 153 $3K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 410 $3K
93975 <1% 77 $3K
73130 <1% 454 $3K
73562 <1% 128 $2K
73564 <1% 349 $2K
90715 <1% 530 $2K
73610 <1% 341 $2K
80320 <1% 427 $2K
93017 <1% 53 $2K
71275 Computed tomographic angiography, chest, with contrast material <1% 101 $2K
96361 Intravenous infusion, hydration; each additional hour <1% 770 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 499 $2K
76770 <1% 31 $2K
83690 <1% 2,192 $2K
85730 <1% 1,300 $2K
12001 <1% 39 $2K
12002 <1% 13 $2K
83735 <1% 1,682 $2K
81003 <1% 1,985 $1K
A9585 Injection, gadobutrol, 0.1 ml <1% 95 $1K
0031A <1% 29 $1K
84702 <1% 411 $1K
A9270 Non-covered item or service <1% 19,643 $1K
84443 Thyroid stimulating hormone (TSH) <1% 423 $1K
80053 Comprehensive metabolic panel <1% 645 $1K
99213 Doctor's office visit, returning patient (routine) <1% 27 $1K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 234 $1K
99214 Doctor's office visit, returning patient (more involved) <1% 17 $1K
80329 <1% 323 $1K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 68 $1K
83880 <1% 327 $990.39
85610 <1% 1,363 $961.69
82805 <1% 181 $872.59
83605 <1% 716 $803.77
87086 Culture, bacterial; quantitative colony count, urine <1% 383 $784.28
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 434 $745.20
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 28 $700.98
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 386 $632.19
85379 <1% 468 $575.53
87631 <1% 134 $570.50
73502 <1% 43 $547.86
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 434 $530.04
96376 <1% 709 $526.40
81001 <1% 1,289 $524.35
82962 <1% 1,053 $502.78
87186 <1% 263 $502.17
76775 <1% 15 $491.17
86850 <1% 299 $479.62
73110 <1% 123 $465.55
84703 <1% 326 $463.89
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 136 $434.44
72110 <1% 24 $398.91
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,814 $384.22
J7030 Infusion, normal saline solution , 1000 cc <1% 1,362 $370.07
87040 <1% 141 $364.00
82550 <1% 371 $359.63
87088 <1% 325 $356.80
86900 <1% 381 $348.13
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 171 $341.41
86901 <1% 377 $303.23
85027 <1% 371 $256.43
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 17 $229.61
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 64 $227.00
87070 <1% 75 $173.67
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,985 $158.13
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 81 $136.53
83036 Hemoglobin; glycosylated (A1C) <1% 202 $127.61
87210 <1% 181 $98.94
84100 <1% 225 $91.25
80061 Lipid panel <1% 118 $87.99
J2704 Injection, propofol, 10 mg <1% 98 $82.15
82010 <1% 82 $81.50
J1953 Injection, levetiracetam, 10 mg <1% 19 $73.40
36415 Collection of venous blood by venipuncture <1% 611 $70.38
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,955 $66.60
J3490 Unclassified drugs <1% 1,944 $62.71
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 145 $58.19
73590 <1% 13 $49.50
J1815 Injection, insulin, per 5 units <1% 1,426 $48.85
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,234 $48.05
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 524 $42.08
J1170 Injection, hydromorphone, up to 4 mg <1% 233 $39.02
84460 <1% 14 $36.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 506 $35.93
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 725 $35.13
82247 <1% 15 $34.65
J1245 Injection, dipyridamole, per 10 mg <1% 41 $32.76
84075 <1% 14 $31.85
82330 <1% 69 $29.47
82248 <1% 12 $27.72
J2060 Injection, lorazepam, 2 mg <1% 576 $24.78
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,241 $23.83
84155 <1% 15 $23.35
73080 <1% 18 $23.00
J3370 Injection, vancomycin hcl, 500 mg <1% 159 $22.48
J1644 Injection, heparin sodium, per 1000 units <1% 242 $19.57
J1650 Injection, enoxaparin sodium, 10 mg <1% 814 $18.74
82040 <1% 15 $18.25
86140 <1% 82 $18.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 576 $17.50
J0690 Injection, cefazolin sodium, 500 mg <1% 49 $14.67
84295 <1% 67 $13.19
84132 <1% 69 $12.87
82435 <1% 67 $12.87
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg <1% 112 $12.04
J3010 Injection, fentanyl citrate, 0.1 mg <1% 117 $10.55
87205 <1% 18 $9.00
J1630 Injection, haloperidol, up to 5 mg <1% 42 $6.96
82947 <1% 69 $4.12
85651 <1% 15 $3.77
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 123 $3.41
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 199 $2.63
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 224 $2.43
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 17 $0.48
91300 <1% 45 $0.06
J3475 Injection, magnesium sulfate, per 500 mg 0% 163 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 175 $0.00
J2310 Injection, naloxone hydrochloride, per 1 mg 0% 29 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 15 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 175 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 271 $0.00
81025 0% 45 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 38 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 40 $0.00
J0280 Injection, aminophyllin, up to 250 mg 0% 24 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGALUP, RICHARD (PRESIDENT)
Same official

Other billing entities under GALUP, RICHARD

Full network →
ProviderLocationPaid
Jefferson Health - NortheastPhiladelphia, PA$5.50M
Jefferson Health - NortheastLanghorne, PA$1.71M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.